NEW YORK (Reuters Health), Feb 20 - The results of a small trial suggest that vitamin B12 is a safe, effective, and inexpensive treatment for repeat canker sores.
"The frequency of (repeat canker sores) is as much as 25% in the general population," researcher Dr. Ilia Volkov, from Ben-Gurion University of the Negev, Beer-Sheva, Israel, said in a statement.
The cause of recurrent canker sores is unknown. Over the years a variety of treatments, including adhesive pastes, antiseptics, vitamins, herbs, and steroids have been tested. Although these treatments may reduce pain or the number of lesions in the short term, very few have had any lasting beneficial effect.
Volkov's team had already discovered that treating recurrent canker sores with vitamin B12 produced lasting results. In their most recent study, which involved 58 volunteers, they wanted to confirm the effectiveness of vitamin B12 by comparing results in treated patients to a comparison group that received inactive "placebo."
The results of the study are reported in the Journal of the American Board of Family Medicine.
Compared to placebo, treatment with vitamin B12 significantly reduced pain, the number of ulcers, and the duration of outbreaks at 5 and 6 months. Moreover, the improvements were not affected by what the patients' blood levels of vitamin B12 were at the start of the study.
In the last month of treatment, 74.1% of vitamin B12-treated patients were free of canker sores compared with 32% of those given placebo.
Exactly how vitamin B12 achieves these beneficial effects is unclear, the authors acknowledge. The fact that the treatment worked equally well regardless of the initial vitamin B12 level suggests that the vitamin may possess some unrecognized functions.
Source: Journal of the American Board of Family Medicine, January/February 2009.
Last Updated: 2009-02-20 14:47:25 -0400 (Reuters Health)
Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
